Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience

Breast cancer patients with triple negative LMD, concomitant brain metastases or LMD affecting both the spine and brain have the poorest prognosis. Clinical trials to identify more effective treatments for these patients are urgently needed.